Identification of type 1 inosine monophosphate dehydrogenase as an antiangiogenic drug target
- PMID: 16640327
- DOI: 10.1021/jm051225t
Identification of type 1 inosine monophosphate dehydrogenase as an antiangiogenic drug target
Abstract
To rapidly discover clinically useful angiogenesis inhibitors, we created and screened a library of existing drugs for inhibition of endothelial cell proliferation. Mycophenolic acid (MPA), an immunosuppressive drug, was found to potently inhibit endothelial cell proliferation in vitro and block tumor-induced angiogenesis in vivo. Using RNA interference, we found that knockdown of one of the two known isoforms of inosine monophosphate dehydrogenase (IMPDH-1) is sufficient to cause endothelial cell cycle arrest.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
